| Dr Kim Ann Suk Baker, MD | |
|
2401 Gillham Rd, Kansas City, MO 64108-4619 | |
| (816) 234-3042 | |
| Not Available |
| Full Name | Dr Kim Ann Suk Baker |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology - Pediatric Otolaryngology |
| Location | 2401 Gillham Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023141413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 2009019884 (Missouri) | Primary |
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Edie Littlefield Sundby may not have thought she'd ignite a national debate when the stage-4 cancer survivor asked us to publish her Monday op-ed on losing her oncologist due to the Affordable Care Act. But she certainly has, and it's important to understand why. Mrs. Sundby and millions like her must be denied their medical choices if ObamaCare is going to work as its liberal planners intend (11/6).
The World Bank and World Health Organization have voiced fears that policymakers will break their commitments to support desperately needed global health services in low- and middle-income countries because of the ongoing global economic downturn. Yet, according to a new study from the Harvard School of Public Health, there is surprisingly little historical evidence to justify reversing these commitments.
Boehringer Ingelheim and Eli Lilly and Company today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin* at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) which will take place in Barcelona, from 23 – 27 September. The presentations will add to the already existing body of data on safety and efficacy of these two compounds.
Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide.
The Minneapolis Heart Institute Foundation today announced the results of survey research aimed at discovering patient and family satisfaction with acute care transfers for patients with STEMI (ST-segment elevation myocardial infarction), a severe heart attack best treated quickly with specialized care.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kim Ann Suk Baker, MD 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3042 | Dr Kim Ann Suk Baker, MD 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3042 |
News Archive
Edie Littlefield Sundby may not have thought she'd ignite a national debate when the stage-4 cancer survivor asked us to publish her Monday op-ed on losing her oncologist due to the Affordable Care Act. But she certainly has, and it's important to understand why. Mrs. Sundby and millions like her must be denied their medical choices if ObamaCare is going to work as its liberal planners intend (11/6).
The World Bank and World Health Organization have voiced fears that policymakers will break their commitments to support desperately needed global health services in low- and middle-income countries because of the ongoing global economic downturn. Yet, according to a new study from the Harvard School of Public Health, there is surprisingly little historical evidence to justify reversing these commitments.
Boehringer Ingelheim and Eli Lilly and Company today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin* at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) which will take place in Barcelona, from 23 – 27 September. The presentations will add to the already existing body of data on safety and efficacy of these two compounds.
Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide.
The Minneapolis Heart Institute Foundation today announced the results of survey research aimed at discovering patient and family satisfaction with acute care transfers for patients with STEMI (ST-segment elevation myocardial infarction), a severe heart attack best treated quickly with specialized care.
› Verified 6 days ago
Dr. Bart C Patenaude, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 15 E 54th St, Kansas City, MO 64110 Phone: 816-519-3013 | |
Dr. Ann Bailey Robinson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr, Suite 450, Kansas City, MO 64114 Phone: 816-942-7200 Fax: 816-941-2767 | |
Dr. Pamela Nicklaus, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Robert Weatherly, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Joseph R Guastello, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4320 Wornall Rd, Ste 512, Kansas City, MO 64111 Phone: 816-932-8663 | |
Dr. Thomas Cotton, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |